NCT00455715View on ClinicalTrials.gov

A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2008

Conditions
Schizophrenia
Interventions
DRUG

Sildenafil

1 capsule Sildenafil 50mg or Sildenafil 100mg or placebo taken at the time of study visit.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00455715 - A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia | Biotech Hunter | Biotech Hunter